IRadimed EBITDA Margin 2013-2024 | IRMD
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for IRadimed (IRMD) over the last 10 years. The current EBITDA margin for IRadimed as of December 31, 2024 is .
| IRadimed EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-12-31 | $0.07B | $0.02B | 31.51% |
| 2024-09-30 | $0.07B | $0.02B | 30.99% |
| 2024-06-30 | $0.07B | $0.02B | 31.43% |
| 2024-03-31 | $0.07B | $0.02B | 30.88% |
| 2023-12-31 | $0.07B | $0.02B | 30.77% |
| 2023-09-30 | $0.06B | $0.02B | 30.16% |
| 2023-06-30 | $0.06B | $0.02B | 30.51% |
| 2023-03-31 | $0.06B | $0.02B | 32.14% |
| 2022-12-31 | $0.05B | $0.02B | 33.96% |
| 2022-09-30 | $0.05B | $0.02B | 34.00% |
| 2022-06-30 | $0.05B | $0.02B | 31.25% |
| 2022-03-31 | $0.05B | $0.01B | 26.67% |
| 2021-12-31 | $0.04B | $0.01B | 23.81% |
| 2021-09-30 | $0.04B | $0.01B | 20.51% |
| 2021-06-30 | $0.04B | $0.01B | 16.67% |
| 2021-03-31 | $0.03B | $0.00B | 3.03% |
| 2020-12-31 | $0.03B | 0 | 0.00% |
| 2020-09-30 | $0.04B | $0.00B | 5.71% |
| 2020-06-30 | $0.04B | $0.00B | 10.81% |
| 2020-03-31 | $0.04B | $0.01B | 25.64% |
| 2019-12-31 | $0.04B | $0.01B | 28.95% |
| 2019-09-30 | $0.04B | $0.01B | 28.57% |
| 2019-06-30 | $0.03B | $0.01B | 24.24% |
| 2019-03-31 | $0.03B | $0.01B | 22.58% |
| 2018-12-31 | $0.03B | $0.01B | 23.33% |
| 2018-09-30 | $0.03B | $0.01B | 20.69% |
| 2018-06-30 | $0.03B | $0.01B | 22.22% |
| 2018-03-31 | $0.03B | $0.01B | 19.23% |
| 2017-12-31 | $0.02B | $0.00B | 12.50% |
| 2017-09-30 | $0.02B | $0.00B | 17.39% |
| 2017-06-30 | $0.03B | $0.01B | 24.00% |
| 2017-03-31 | $0.03B | $0.01B | 27.59% |
| 2016-12-31 | $0.03B | $0.01B | 36.36% |
| 2016-09-30 | $0.04B | $0.01B | 38.89% |
| 2016-06-30 | $0.04B | $0.01B | 38.89% |
| 2016-03-31 | $0.03B | $0.01B | 41.18% |
| 2015-12-31 | $0.03B | $0.01B | 37.50% |
| 2015-09-30 | $0.03B | $0.01B | 29.63% |
| 2015-06-30 | $0.02B | $0.01B | 21.74% |
| 2015-03-31 | $0.02B | $0.00B | 20.00% |
| 2014-12-31 | $0.02B | $0.00B | 17.65% |
| 2014-09-30 | $0.02B | $0.01B | 37.50% |
| 2014-06-30 | $0.01B | $0.01B | 42.86% |
| 2014-03-31 | $0.01B | $0.01B | 41.67% |
| 2013-12-31 | $0.01B | $0.01B | 63.64% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.673B | $0.073B |
| iRadimed Corporation engages in developing, manufacturing, marketing, and distributing magnetic resonance imaging (MRI) compatible products. It offers non-magnetic intravenous (IV) infusion pump systems, IV tubing sets, IV poles, wireless remote displays/controls under the mRidium name; side car pump modules; dose error reduction systems; Masimo SET SpO2 monitoring products; and MRI Pulse oximeters, and MRI oximeter remotes and displays under the iMagox name used during MRI procedures. iRadimed Corporation is headquartered in Winter Park, Florida. | |||